AddThis

Ligand releases details of plan to purchase Pharmacopeia

Related Content

No related items were found.

SAN DIEGO Ligand Pharmaceutical plans to buy New Jersey biotech Pharmacopeia for as much as $70 million, the San Diego drug maker has announced.

Ligand’s shareholders will get an 84 percent stake in the new company, while Pharmacopeia shareholders would get a little more than half a share in Ligand for every Pharmacopeia share they own. That makes the deal worth $1.81 per share.

The deal will probably close in the first three months of next year, depending on regulatory and shareholder approvals.

© 2014 Drug Store News. All Rights Reserved.